Categories: AutomationBioTechDataDevelopmentDrugFutureInterestLearnMedtechPlatform
Cultivated with love by the Orakl team.
Investors 4
Funding Rounds 1
| Date | Series | Amount | Investors |
| 04.10.2023 | - | $3.16M | - |
Mentions in press and media 2
| Date | Title | Description |
| 04.10.2023 | Orakl Oncology bag €3M to propel techbio platform for accelerated cancer drug development | Read this article in:
France-based Orakl Oncology, a precision oncology drug discovery start-up, announced that it has raised €3M to develop its techbio platform. The company claims the platform integrates biology and real-world patient dat... |
| 04.10.2023 | Orakl Oncology Raises €3M in Funding | Orakl Oncology, a Paris, France-based precision oncology startup, raised €3M in funding.
The round was led by Speedinvest with additional investment from HCVC and Verve Ventures.
Orakl Oncology is combining cell biology, engineering and mac... |
Reviews 0
